World Inside a facility that could mass produce a COVID-19 vaccine
Poll: Number of Americans willing to get a vaccination falls as fears mount that Trump is putting politics before safety
Now, four months later, less than a third of Americans (32 percent) say they plan to get vaccinated, according to the latest Yahoo News/YouGov poll — a stunning 23-point decline that reflects rising concern about the politicization of the vaccine process and underscores how challenging it will be to stop the pandemic through vaccination alone. As recently as late July, 42 percent of Americans had said they planned to get vaccinated, meaning 10 percent of the public has moved into the “no” or “not sure” column over the last month or so. © Provided by Yahoo! News The question is why.
The number of reported cases around the world has just topped 30 million. The World Health Organization "alarming rates of transmission" can be seen again in Europe, which brings new urgency to the global search for a .
There are 36 vaccines for COVID-19 currently in human trials, according to WHO.
Trump says CDC Director Robert Redfield 'confused' about coronavirus vaccine, mask efficacy. Redfield responded.
Donald Trump took issue with CDC director Robert Redfield's comments that face masks are more effective than a vaccine at stopping spread of COVID.Hurricane Sally power outages top 540,000 in Alabama, Florida and Georgia
In a rare look inside a Wockhardt UK facility in Britain, CBS News foreign correspondent Holly Williams saw how a vaccine would be produced for widespread use.
At the facility, a sterile production line could be mass producing a vaccine within weeks. Right now, they're training staff by filling glass vials with water.
They could start filling vials with a vaccine as early as November, maybe even before a vaccine has been approved. That's because as soon as they get that final approval, they want to be sending it out to the public.
"These are unprecedented times and require unprecedented initiatives," said managing director of Wockhardt UK Ravi Limaye.
Limaye told Williams his facility can produce up to 240 million doses of a new vaccine in a year.
But if the vaccine they start producing doesn't get approved for safety, they'll simply have to throw it out.
Asked if it is a gamble to start packaging millions of doses of a vaccine before it has final approval, Limaye said, "I won't say it's a gamble. I would say this is investment in public health."
5 things to know about Moderna's coronavirus vaccine
CBS News spoke to Moderna's president, Dr. Stephen Hoge, for the "CBS Evening News" series Racing to a Cure.Here are our top takeaways from that conversation:
The , arguably the front-runner in the race to stop the new virus despite a recent pause in its trial, will likely be produced at the facility.
The U.S. government has given more than $1 billion to the drug company behind it, AstraZeneca, to secure at least 300 million doses.
The world's biggest vaccine manufacturer, based in India, warned this week that production isn't being ramped up quickly enough, and it could take until 2024 to produce enough doses of vaccine to cover the entire world.
Video: Doctor "wouldn't trust" COVID-19 vaccine if it hasn't completed clinical trials (CBS News)
Fact check: Claim of double standards between COVID-19, swine flu responses is inaccurate .
The claim correctly cites Swine flu case counts but is inaccurate on other points, including the response to H1N1.Trump: Biden doesn't know Black voters 'like I do'